Cargando…
Amelioration of murine sickle cell disease by nonablative conditioning and γ-globin gene-corrected bone marrow cells
Patients with severe sickle cell disease (SCD) are candidates for gene therapy using autologous hematopoietic stem cells (HSCs), but concomitant multi-organ disease may contraindicate pretransplant conditioning with full myeloablation. We tested whether nonmyeloablative conditioning, a regimen used...
Autores principales: | Pestina, Tamara I, Hargrove, Phillip W, Zhao, Huifen, Mead, Paul E, Smeltzer, Matthew P, Weiss, Mitchell J, Wilber, Andrew, Persons, Derek A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4667717/ https://www.ncbi.nlm.nih.gov/pubmed/26665131 http://dx.doi.org/10.1038/mtm.2015.45 |
Ejemplares similares
-
Cells Capable of Bone Production Engraft from Whole Bone Marrow Transplants in Nonablated Mice
por: Nilsson, Susan K., et al.
Publicado: (1999) -
Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations
por: Woodard, Kaitly J., et al.
Publicado: (2022) -
Spermatogonial stem cell transplantation into nonablated mouse recipient testes
por: Morimoto, Hiroko, et al.
Publicado: (2021) -
Nonablative facelift in Indian skin with superpulsed radiofrequency
por: Sharad, Jaishree
Publicado: (2011) -
Sickle cell anemia: clinical diversity and beta S-globin haplotypes
por: Loggetto, Sandra Regina
Publicado: (2013)